Advertisement
U.S. markets close in 1 hour 9 minutes
  • S&P 500

    5,089.29
    +2.26 (+0.04%)
     
  • Dow 30

    39,100.12
    +31.01 (+0.08%)
     
  • Nasdaq

    16,009.86
    -31.76 (-0.20%)
     
  • Russell 2000

    2,018.84
    +5.00 (+0.25%)
     
  • Crude Oil

    76.57
    -2.04 (-2.60%)
     
  • Gold

    2,048.20
    +17.50 (+0.86%)
     
  • Silver

    23.00
    +0.22 (+0.95%)
     
  • EUR/USD

    1.0824
    -0.0004 (-0.03%)
     
  • 10-Yr Bond

    4.2560
    -0.0710 (-1.64%)
     
  • GBP/USD

    1.2674
    +0.0016 (+0.13%)
     
  • USD/JPY

    150.4540
    -0.0460 (-0.03%)
     
  • Bitcoin USD

    51,126.08
    -341.55 (-0.66%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,706.28
    +21.79 (+0.28%)
     
  • Nikkei 225

    39,098.68
    +836.48 (+2.19%)
     

Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

Avid Bioservices, Inc
Avid Bioservices, Inc

TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the RBC Capital Markets Virtual CDMO Conference. Nick Green, president and chief executive officer, will be the featured speaker in a fireside chat at the conference, which will take place October 2-3, 2023.

Details of the company’s participation are as follows:

  • RBC Capital Markets Virtual CDMO Conference
    Conference Date: October 2-3, 2023
    Fireside Chat Time/Date: 11:00 – 11:30 a.m. Eastern on Tuesday, October 3, 2023

About Avid Bioservices, Inc.

Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 30 years of experience producing biologics, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com

CONTACT: Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) Vida Strategic Partners 415-675-7402 tbrons@vidasp.com


Advertisement